EPTINEZUMAB
eptinezumab 100 mg/mL injection, 1 mL vial
EPTINEZUMAB (13352R)
13352R
Body System:
Manner of administration:Injection
Restriction 12029
Indication: Chronic migraine
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 1 | DPMQ: $1,449.11 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Vyepti | |||||